Ethic Inc. grew its holdings in shares of Globe Life Inc. (NYSE:GL – Free Report) by 36.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,988 shares of the company’s stock after buying an additional 3,967 shares during the quarter. Ethic Inc.’s holdings in Globe Life were worth $2,678,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. Jupiter Asset Management Ltd. acquired a new position in Globe Life during the fourth quarter valued at approximately $2,073,000. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Globe Life by 34,786.0% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 881,919 shares of the company’s stock valued at $123,345,000 after buying an additional 879,391 shares during the last quarter. Strs Ohio boosted its holdings in shares of Globe Life by 213.7% in the 4th quarter. Strs Ohio now owns 21,907 shares of the company’s stock valued at $3,064,000 after buying an additional 14,924 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of Globe Life by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock valued at $1,411,311,000 after buying an additional 86,349 shares in the last quarter. Finally, Handelsbanken Fonder AB increased its holdings in Globe Life by 23.1% during the fourth quarter. Handelsbanken Fonder AB now owns 75,235 shares of the company’s stock worth $10,522,000 after buying an additional 14,135 shares during the last quarter. Institutional investors own 81.61% of the company’s stock.
Insiders Place Their Bets
In other news, CEO James Matthew Darden sold 50,000 shares of Globe Life stock in a transaction on Friday, July 31st. The stock was sold at an average price of $182.43, for a total transaction of $9,121,500.00. Following the completion of the sale, the chief executive officer owned 58,451 shares of the company’s stock, valued at approximately $10,663,215.93. This trade represents a 46.10% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Michael Clay Majors sold 37,000 shares of the business’s stock in a transaction dated Wednesday, July 29th. The shares were sold at an average price of $178.64, for a total transaction of $6,609,680.00. Following the completion of the sale, the executive vice president directly owned 53,518 shares of the company’s stock, valued at approximately $9,560,455.52. The trade was a 40.88% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 191,747 shares of company stock worth $33,480,408 over the last three months. 2.11% of the stock is currently owned by corporate insiders.
Globe Life Stock Up 1.8%
Globe Life (NYSE:GL – Get Free Report) last issued its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.67 by ($0.06). Globe Life had a return on equity of 20.52% and a net margin of 19.58%.The company had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter last year, the business earned $3.05 earnings per share. The company’s revenue was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, analysts forecast that Globe Life Inc. will post 15.71 earnings per share for the current year.
Globe Life announced that its Board of Directors has authorized a stock repurchase program on Monday, August 10th that allows the company to repurchase $2.50 billion in shares. This repurchase authorization allows the company to buy up to 17.7% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s leadership believes its shares are undervalued.
Globe Life Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, October 5th will be paid a $0.33 dividend. The ex-dividend date is Monday, October 5th. This represents a $1.32 annualized dividend and a yield of 0.7%. Globe Life’s payout ratio is 8.76%.
Analysts Set New Price Targets
GL has been the subject of a number of analyst reports. Wells Fargo & Company lifted their price objective on shares of Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a research report on Thursday, July 9th. Piper Sandler lifted their price target on Globe Life from $175.00 to $200.00 and gave the stock an “overweight” rating in a report on Wednesday, July 15th. Weiss Ratings lowered Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, July 20th. Truist Financial raised their price objective on Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research report on Friday, April 24th. Finally, JPMorgan Chase & Co. boosted their target price on Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a report on Tuesday, July 21st. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, Globe Life currently has a consensus rating of “Moderate Buy” and an average price target of $191.67.
Get Our Latest Report on Globe Life
Globe Life Company Profile
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
See Also
- Five stocks we like better than Globe Life
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL – Free Report).
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
